| Wellcare Texas Medicare Clinical | V1.2025 Concert Genetics Oncology: Cancer Screening | 2024-11-01 |
| Wellcare Texas Medicare Clinical | V1.2025 Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) | 2024-11-01 |
| Wellcare Texas Medicare Clinical | V1.2025 Concert Genetics Oncology: Cytogenetic Testing | 2024-11-01 |
| Wellcare Texas Medicare Clinical | Concert Genetic Testing Oncology: Molecular Analysis of Solid Tumors and | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Outpatient Oxygen Use | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Concert Genetic Testing: Aortopathies and Connective Tissue Disorders | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Concert Genetic Testing: Cardiac Disorders | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Concert Genetic Testing: Dermatologic Conditions | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular | 2024-11-01 |
| Wellcare Vermont Medicare Clinical | Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis | 2024-11-01 |